Managing GLP-1 Side Effects: Nausea, Fatigue, and 'Sulfur Burps

GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda) — are among the most effective obesity and diabetes medications available. They're also known for a distinct set of gastrointestinal side effects that, for some people, are the deciding factor in whether they stay on treatment.

The good news: most of these side effects are predictable, manageable, and temporary. They're most intense during dose escalation and tend to diminish as your body adapts. Knowing what to expect — and having practical strategies ready — dramatically improves tolerability.

Why GLP-1s Cause GI Side Effects

The mechanism is tied directly to how these drugs work. GLP-1 receptors are found throughout the gastrointestinal tract. When a GLP-1 receptor agonist activates these receptors, it:

• Slows gastric emptying — food stays in your stomach longer, which is part of why you feel full faster but also contributes to nausea, reflux, and constipation
• Reduces gut motility — slowing the movement of contents through the intestine
• Acts on the brainstem's vomiting center (area postrema) — GLP-1 receptors are present in the nausea/vomiting control centers of the brain

This isn't a sign the medication is harming you. It's the mechanism of action, and it's why the titration schedule exists — slow dose increases allow these receptors to adapt gradually.

In the STEP 1 clinical trial of semaglutide, nausea was reported by 44% of participants, vomiting by 24%, diarrhea by 30%, and constipation by 24% at some point over 68 weeks. Most events were mild-to-moderate in severity. Discontinuation due to GI events occurred in about 4.5% of participants.

Nausea: The Most Common Complaint

What It Feels Like

Most people describe GLP-1 nausea as a persistent background queasiness rather than acute, acute stomach upset. It's often worse in the first day or two after injection and improves by the end of the week. At higher doses, it can be more intense.

Evidence-Based Strategies

1. Inject at night before bed Timing your injection for the evening means the peak plasma concentration — and peak nausea — occurs while you're asleep. Many clinicians and patients report this as the single most effective adjustment. There is no published head-to-head trial comparing morning vs. evening injection for nausea, but clinical experience strongly supports this approach.

2. Eat smaller, more frequent meals A full stomach on top of slowed gastric emptying is a reliable nausea trigger. Aim for 3–4 small meals rather than 2–3 large ones. Keep portions to roughly half what you'd normally eat. Eating slowly and stopping before you feel "full" (rather than after) reduces post-meal nausea significantly.

3. Avoid high-fat and high-sugar meals post-injection Fat slows gastric emptying independently of GLP-1 medication. Eating a fatty meal when your stomach is already emptying more slowly is a recipe for prolonged nausea. Similarly, large sugar loads can worsen GI symptoms. Lean proteins, cooked vegetables, and plain starches (rice, oats) are easier on the system during adjustment.

4. Stay hydrated Dehydration worsens nausea. Aim for at least 64 oz of water daily. Sipping slowly throughout the day is better tolerated than drinking large amounts at once. Electrolyte beverages without high sugar content (like Liquid IV or plain coconut water) can help if you've been vomiting.

5. Ginger Ginger has robust evidence for nausea reduction across multiple contexts (pregnancy, chemotherapy, motion sickness). A 2014 systematic review in Nutrition Journal found ginger significantly reduces nausea scores. Ginger tea, ginger chews, or ginger capsules (500–1000 mg) before meals may help.

6. Ask about anti-nausea medication If nausea is significantly impacting your quality of life or food intake, speak with your provider. Ondansetron (Zofran), typically used for chemotherapy nausea, is sometimes prescribed short-term for GLP-1 users. Promethazine is another option. These are not routinely necessary but are legitimate tools for patients who struggle during dose escalation.

Sulfur Burps: The Side Effect Nobody Talks About (Until It Happens to Them)

What They Are

"Sulfur burps" — belching with a rotten egg or sulfur smell — are one of the most unpleasant and least-discussed side effects of GLP-1 medications. They occur because slowed gastric emptying means food sits in the stomach longer, fermenting and producing hydrogen sulfide gas. This gas, when released via belching, has a distinctive rotten-egg odor.

They're not a sign of infection or disease. But they can be socially distressing and indicate your GI system is working especially slowly.

Managing Sulfur Burps

• Eat smaller portions, more slowly: Less food in the stomach means less fermentation opportunity.
• Avoid sulfur-rich foods during dose escalation: Eggs, red meat, cruciferous vegetables (broccoli, cauliflower, cabbage), and dairy all contain sulfur compounds. Temporarily reducing these — especially on injection days — can help.
• Avoid carbonated beverages: Carbonation adds gas on top of GI gas, worsening the problem.
• Simethicone (Gas-X): An OTC gas-relief medication. Simethicone breaks up gas bubbles in the stomach and can reduce burping. It's not absorbed systemically, so it's safe to use alongside GLP-1 medication.
• Pepcid (famotidine): Some users find an OTC H2 blocker helps with both reflux and the frequency of burping. Ask your provider if this seems warranted.
• Bismuth subsalicylate (Pepto-Bismol): Bismuth is known to bind hydrogen sulfide and may reduce sulfur smell. Note that it contains aspirin-related compounds and should be used cautiously in people with aspirin sensitivity.

Constipation: The Slow-Motion Problem

GLP-1-induced constipation is common and underreported, partly because people feel embarrassed discussing it. In the SURMOUNT-1 trial of tirzepatide, constipation was reported in 17% of participants on the 15 mg dose.

Slowed GI motility means stool spends more time in the colon, where more water is absorbed — resulting in harder, harder-to-pass stool.

Practical Solutions

• Increase fluid intake first. Most GLP-1-induced constipation responds well to hydration. Aim for 8–10 cups of water daily.
• Increase dietary fiber gradually. Soluble fiber (oats, psyllium, beans) adds bulk and draws water into stool. Insoluble fiber (vegetables, whole grains) speeds transit. Start slowly — increasing fiber too rapidly can cause cramping and gas.
• Psyllium husk (Metamucil): One of the most evidence-backed fiber supplements for constipation. Mix with plenty of water.
• Daily movement: Even a 20-minute walk can stimulate bowel motility. Physical activity promotes the gastrocolic reflex.
• Magnesium citrate: A gentle, osmotic laxative available OTC. 200–400 mg at bedtime is a common approach. Unlike stimulant laxatives, it doesn't cause dependency. Always check with your provider first, especially if you have kidney disease.
• Avoid stimulant laxatives as a first line: Senna and bisacodyl work but can cause dependence with regular use. Reserve for acute relief, not daily management.

Diarrhea and Loose Stools

Less commonly, GLP-1s cause the opposite problem — loose stools or diarrhea. This is more common early in treatment and usually self-resolves. If it persists:

• Eat a low-fat, low-fiber diet temporarily
• Avoid lactose and high-fructose foods
• Stay well hydrated with electrolyte-containing fluids
• OTC loperamide (Imodium) is safe for short-term use
• Persistent diarrhea lasting more than 2 weeks warrants a provider call

Fatigue

Fatigue during the early weeks of GLP-1 treatment usually has multiple contributing factors:

1. Reduced caloric intake — the body has less fuel
2. Lower carbohydrate intake — if your eating naturally shifts lower-carb, your energy may dip while adapting
3. Possible mild dehydration — from reduced food intake (food provides meaningful water)
4. The medication itself — some patients report tiredness that is not fully explained by intake changes

What Helps

• Ensure adequate protein and calories. Undereating is the most common culprit. If you're consistently below 1,000–1,200 kcal/day, fatigue is expected. Check your intake with a logging app, even briefly.
• Maintain carbohydrate intake at a reasonable level. Extreme low-carb eating on top of GLP-1-suppressed appetite can cause fatigue and brain fog. Unless advised by your provider, don't eliminate carbohydrates.
• Check labs. Fatigue can be a sign of anemia, thyroid dysfunction, or deficiencies in iron, B12, or vitamin D — all of which are common in people with obesity or metabolic disease, independent of medication. A comprehensive metabolic panel and CBC are worth requesting if fatigue persists beyond 4 weeks.
• Prioritize sleep. GLP-1 users often report improved sleep as weight loss progresses — but early on, disrupted sleep from GI discomfort can worsen fatigue.

When to Call Your Provider

Most side effects are manageable with lifestyle adjustments. However, some warrant prompt medical attention:

Symptom	Action
Severe, persistent abdominal pain (especially radiating to the back)	Call immediately — may indicate pancreatitis
Vomiting so frequent you can't keep liquids down	Seek care for dehydration/medication adjustment
Significant pain in upper right abdomen	Possible gallbladder issue (gallstones are a known GLP-1 risk)
Rapid heart rate, chest pain	Seek emergency care
Blood in stool	Call your provider

The FDA label for Ozempic lists acute pancreatitis as a warning, though it is rare. Gallbladder disease is also a noted risk, particularly with rapid weight loss.

A Note on Dose Pauses

If side effects are significantly impacting your ability to eat, drink, or function, contact your prescriber about pausing or slowing your dose escalation. There's no clinical disadvantage to staying at a lower dose for an extra 4 weeks. The STEP and SURMOUNT trials used standardized escalation schedules, but real-world prescribing allows flexibility. A slow titration schedule often leads to better long-term adherence.

Sources

1. Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." NEJM, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
2. Joshi SR, et al. "SURMOUNT-1: Tirzepatide for Obesity." NEJM, 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
3. FDA. "Ozempic (semaglutide) Prescribing Information." https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s012lbl.pdf
4. Lete I, Allué J. "The Effectiveness of Ginger in the Prevention of Nausea and Vomiting." Nutrition Journal, 2016. https://nutritionj.biomedcentral.com/articles/10.1186/1475-2891-13-20
5. Davies M, et al. "Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2)." The Lancet, 2021. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00213-0/fulltext
6. Rubino D, et al. "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity." JAMA, 2021. https://jamanetwork.com/journals/jama/fullarticle/2777886